SWOG clinical trial number
SWOG-7804

Adjuvant Chemotherapy with 5-Fluorouracil, Adriamycin and Mitomycin-C (FAM) Versus Surgery Alone for Patients with Locally Advanced Gastric Adenocarcinoma

Closed
Phase
Accrual
100%
Published
Abbreviated Title
Adjuvant Chemotherapy with 5-Fluorouracil, Adriamycin and Mitomycin-C (FAM) Versus Surgery Alone for Patients with Locally Advanced Gastric Adenocarcinoma
Activated
03/10/1978
Closed
08/15/1991

Publication Information Expand/Collapse

1995

Adjuvant chemotherapy with 5-FU, adriamycin and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study.

JS Macdonald;TR Fleming;RF Peterson;JL Berenberg;S McClure;RA Chapman;HJ Eyre;D Solanki;AB Cruz Jr;R Gagliano;NC Estes;CM Tangen;S Rivkin Annals of Surgical Oncology 2(6):488-494

1992

A phase III trial of FAM (5-fluorouracil, adriamycin, mitomycin-C) chemotherapy vs control as adjuvant treatment for resected gastric cancer: A Southwest Oncology Group trial.

JS Macdonald;R Gagliano;T Fleming;N Estes ASCO 11:168(#488)

1983

Adjuvant chemotherapy with 5-Fluorouracil, Adriamycin and Mitomycin (FAM) in gastric cancer - A SWOG study.

R Gagliano;JD McCracken;T Chen ASCO #C-443